- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Epidermal growth factor receptor
Total 57875 results
-
Hoffmann-La RocheCompletedBladder Cancer | Pancreas Cancer | Cholangiocellular CarcinomaSpain, Italy, Netherlands, Slovakia
-
National Cancer Institute (NCI)CompletedGlioblastoma | Brain Cancer | Malignant Glioma | GliosarcomaUnited States
-
Clovis Oncology, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, France, Germany, Netherlands, Australia, Spain, Taiwan, United Kingdom, Italy
-
Johannes Gutenberg University MainzPierre Fabre Pharma GmbHCompleted
-
AmgenActavis Inc.CompletedBreast CancerItaly, Hungary, Russian Federation, South Africa, Spain, Serbia, Belarus, Ukraine, Chile, Germany, Bulgaria, Greece, Poland, Canada, Brazil, Mexico, Romania, United Kingdom
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Eli Lilly and CompanyCompleted
-
Shen LinUnknownColorectal Cancer | Esophageal Squamous Cell Carcinoma | Biliary Tract Cancer | Targeted Therapy | HER2China
-
AbbVieNo longer availableGlioblastoma or Solid Tumors, Epidermal Growth Factor Receptor (EGFR) Diagnosis
-
Hoffmann-La RocheCompletedBreast NeoplasmsCanada, United States, France, Korea, Republic of, Spain, Belgium, Germany, Russian Federation, Taiwan, Ukraine
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
Novartis PharmaceuticalsTerminatedCancerUnited States, Canada
-
Hoffmann-La RocheCompletedBreast CancerKazakhstan, Belarus
-
Clovis Oncology, Inc.TerminatedNon-Small Cell Lung CancerKorea, Republic of, United States, Spain, Hong Kong, Taiwan, Germany, Italy
-
Northwestern UniversityGenentech, Inc.; Amgen; OSI PharmaceuticalsCompleted
-
Rabin Medical CenterUnknownBasal Cell Carcinoma | Squamous Cell CarcinomaIsrael
-
Hoffmann-La RocheCompletedBreast CancerTurkey, Algeria, Morocco, Saudi Arabia, Tunisia
-
Hoffmann-La RocheCompleted
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
GlaxoSmithKlineCompleted
-
Astellas Pharma Global Development, Inc.Terminated
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
Sierra Oncology, Inc.TerminatedEGFR Mutated EGFR TKI Naive Metastatic NSCLCUnited States
-
Haihua YangUnknown
-
Sinocelltech Ltd.Tianjin Medical University Cancer Institute and HospitalUnknownEsophageal Squamous Cell CarcinomaChina
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Clifford Hospital, Guangzhou, ChinaUnknownCarcinoma, Non-Small-Cell LungChina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSerbia, Thailand, Poland, Romania, Egypt, Philippines, Malaysia
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Shi YuankaiUnknownHead and Neck Squamous Cell Carcinoma
-
AstraZenecaWithdrawnNon-small Cell Lung Cancer
-
Eisai Inc.Completed
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPortugal
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
Sinocelltech Ltd.UnknownTriple Negative Breast NeoplasmsChina
-
Sinocelltech Ltd.UnknownAdvanced Solid TumorsChina
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Gary SchwartzUniversity of Colorado, Denver; North Shore University HospitalTerminatedMetastatic Breast CancerUnited States
-
University of ArizonaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
University of NairobiConsortium for Advanced Research Training in Africa (CARTA); Innovix Pharma...Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University...CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
PfizerCompletedER/PR(+), Her2(-) Breast CancerTaiwan
-
Sun Yat-sen UniversityUnknown
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
Hanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Taizhou HospitalCompletedNasopharyngeal CarcinomaChina